Published in Crit Care on January 01, 1985
Evolution of liver transplantation. Hepatology (1982) 19.54
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow. Surg Gynecol Obstet (1960) 11.73
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
Experimental whole-organ transplantation of the liver and of the spleen. Ann Surg (1960) 9.58
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet (1963) 8.04
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery (1965) 6.71
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Kidney transplantation in modified recipients. Ann Surg (1962) 4.66
Studies on the rejection of the transplanted homologous dog liver. Surg Gynecol Obstet (1961) 3.81
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
A new method for one-stage hepatectomy for dogs. Surgery (1959) 3.11
Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Canine liver homotransplants. The effect of host and graft irradiation. Arch Surg (1962) 1.23
SPLENECTOMY AND THYMECTOMY IN HUMAN RENAL HOMOTRANSPLANTATION. Proc Soc Exp Biol Med (1964) 1.20
The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy. Surgery (1980) 1.10
Eleven and two-thirds years' survival after canine orthotopic liver transplantation. Transplantation (1977) 1.04
Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc (1985) 1.04
Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96
Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol (2006) 3.07
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant (2005) 2.54
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30
THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet (1968) 2.20
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75
Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73
Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med (2005) 1.67
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Liver Transpl (2006) 1.41
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18
OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11
Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. Blood (2003) 1.10
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10
Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol (2008) 1.04
Anger as Seeing Red: Perceptual Sources of Evidence. Soc Psychol Personal Sci (2010) 1.02
The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant (2005) 1.02
Humoral Antibodies in Patients After Renal Homotransplantation. Transplantation (1967) 0.96
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant (2005) 0.95
Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status. Immunology (2013) 0.95
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94
Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation (2003) 0.93
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl (2005) 0.93
Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection. Am J Transplant (2003) 0.92
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. J Clin Oncol (2005) 0.92
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91
Portosystemic shunts in children: a 15-year experience. J Am Coll Surg (2004) 0.90
Tacrolimus (FK506)-Associated Renal Pathology. Adv Anat Pathol (1997) 0.90
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89
Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes. Clin Transplant (2005) 0.89
Attention to smoking-related and incongruous objects during scene viewing. Acta Psychol (Amst) (2008) 0.89
Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival. Am J Transplant (2004) 0.88
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol (2002) 0.88
Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med (2008) 0.88
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87
The treatment of penetrating wounds of the inferior vena cava. Surgery (1962) 0.86
Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol (2010) 0.85
Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int (2007) 0.83
Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients. Nephrol Dial Transplant (2004) 0.82
Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood (2006) 0.82
Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome. Ann Surg (2002) 0.82
Smooth muscle tumor arising de novo in a liver allograft: A case report. Clin Transplant (1991) 0.82
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation (2006) 0.82
Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation (2002) 0.81
Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. Clin Transplant (1989) 0.81
Pancreatic transplantation at the University of Pittsburgh. Clin Transpl (2004) 0.81
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant (1992) 0.80
CONSENSUS CONFERENCE REPORT ON LIVER* TRANSPLANTATION. Dializ Transplant Yanik (1983) 0.80
Living and deceased donor liver transplantation for unresectable hepatoblastoma at a single center. Clin Transplant (2005) 0.79
Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk. Kidney Int Suppl (2010) 0.79
Contextual influences on rapid object categorization in natural scenes. Brain Res (2011) 0.79
LIVER TRANSPLANTATION IN MAN. Ann N Y Acad Sci (1970) 0.78
Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation (2009) 0.78
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation (2007) 0.78
Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci (1992) 0.78
Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplant (1992) 0.78
Tolerance for organ recipients: a clash of paradigms. Liver Transpl (2006) 0.78
Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78
Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients. Pediatr Transplant (2006) 0.78
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. Transplant Sci (1993) 0.78
The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation (2006) 0.78
The influence of location and visual features on visual object memory. Mem Cognit (2010) 0.77
Acute Budd-Chiari syndrome during pregnancy: surgical treatment and orthotopic liver transplantation with successful completion of the pregnancy. Liver Transpl (2003) 0.77
Kidney/Bone Marrow Transplantation. Dial Transplant (1996) 0.76
Hepatic Regeneration. Viewp Dig Dis (1979) 0.75
Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation (1997) 0.75
Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Transplant (1993) 0.75
The Problem of Frostbite in Civilian Medical Practice. Surg Clin North Am (1963) 0.75
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki (1995) 0.75
Blood Vessel Bank: Organization and Function. Bull Univ Miami Sch Med Jackson Meml Hosp (1957) 0.75
On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant (1997) 0.75
Effect of homograft ischemia upon serum proteins after orthotopic liver transplantation. Surgery (1968) 0.75
Pancreatic complications following orthotopic liver transplantation. Clin Transplant (1992) 0.75
Successful salvage of mucormycosis infection of the forearm and osteomyelitis of the ulna. Hand (N Y) (2008) 0.75
Deep blue polemics. Liver Transpl (2002) 0.75
Cadaveric Renal Transplantation in Diabetics in the 1980's: with Special Reference to Cyclosporine. Diabet Nephrop (1983) 0.75
World's longest surviving liver-pancreas recipient. Liver Transpl (2007) 0.75
LONG TERM RESULTS OF HEPATIC TRANSPLANTATION DURING THE CYCLOSPORINE ERA: THE PITTSBURGH EXPERIENCE. Transplant Clin Immunol (1987) 0.75
Causes of death after liver transplantation in children treated with cyclosporine and steroids. Clin Transplant (1989) 0.75
Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants. Clin Transplant (1987) 0.75
Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations. Transplantation (2007) 0.75